Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Decitabine in Treating Patients With MyelofibrosisHemic and Lymphatic Diseases, Myeloproliferative Disorders, bone marrow disorder, hematologic disorder, primary myelofibrosisActive, not recruitingPhase 22026-08-26NCT00095784

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
National Cancer Institute (NCI)3015

14 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Central Illinois Hematology Oncology CenterSpringfieldUnited States44
Decatur Memorial HospitalDecaturUnited States303
Fort Wayne Medical Oncology and Hematology Inc-ParkviewFort WayneUnited States20
Illinois CancerCare-PeoriaPeoriaUnited States263
Ingalls Memorial HospitalHarveyUnited States100
Loyola University Medical CenterMaywoodUnited States258
Medical College of WisconsinMilwaukeeUnited States483
Northern Indiana Cancer Research ConsortiumSouth BendUnited States20
NorthShore University HealthSystem-Evanston HospitalEvanstonUnited States127
Ohio State University Comprehensive Cancer CenterColumbusUnited States548
Oncology Care Associates PLLCSaint JosephUnited States4
Southern Illinois University School of MedicineSpringfieldUnited States305
University of Chicago Comprehensive Cancer CenterChicagoUnited States273
University of Maryland/Greenebaum Cancer CenterBaltimoreUnited States152